The Future of Prefilled Syringes: Rapid Growth Expected to Continue

left hand static image

The Future of Prefilled Syringes: Rapid Growth Expected to Continue

If you ask, “What is the fastest-growing injection format in the U.S. and worldwide?”, the answer is one that some people may find surprising

  • Faster administration
  • Significantly reduced waste
  • Error-free dosings
  • Fewer wrong meds given
  • Less chance of needlestick injuries.
  • No cross-contamination at the point of care
* indicates required

Beth Totin

CHIEF COMMERCIAL OFFICER

With 20+ years of experience in marketing and business development, Beth Totin has spearheaded the growth of BFS and traditional glass filling (PFS, vials and cartridge) manufacturing and commercialization efforts for several multinational contract manufacturing organizations.

Prior to joining ApiJect, Beth was responsible for the introduction of a new manufacturing facility in North America for Unither Pharmaceuticals (France), significantly scaling the site for sterile and oral product technologies. During her time at Siegfried, Beth directed innovation efforts around biologics and delivery devices through domestic and international production sites of glass ampoules, vials, cartridges, and BFS. At Catalent, she expanded the customer base by helping to create a new injectable BFS product offering while overseeing a domestic BFS manufacturing site and multiple international sites serving global customers.